Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, Georgia, USA.
Children's Heart Research and Outcomes (HeRO) Center, Children's Healthcare of Atlanta & Emory University, Atlanta, Georgia, USA.
Stem Cells. 2021 Dec;39(12):1650-1659. doi: 10.1002/stem.3445. Epub 2021 Sep 4.
Ischemic heart diseases (IHDs), including myocardial infarction and cardiomyopathies, are a leading cause of mortality and morbidity worldwide. Cardiac-derived stem and progenitor cells have shown promise as a therapeutic for IHD but are limited by poor cell survival, limited retention, and rapid washout. One mechanism to address this is to encapsulate the cells in a matrix or three-dimensional construct, so as to provide structural support and better mimic the cells' physiological microenvironment during administration. More specifically, the extracellular matrix (ECM), the native cellular support network, has been a strong candidate for this purpose. Moreover, there is a strong consensus that the ECM and its residing cells, including cardiac stem cells, have a constant interplay in response to tissue development, aging, disease progression, and repair. When externally stimulated, the cells and ECM work together to mutually maintain the local homeostasis by initially altering the ECM composition and stiffness, which in turn alters the cellular response and behavior. Given this constant interplay, understanding the mechanism of bidirectional cell-ECM interaction is essential to develop better cell implantation matrices to enhance cell engraftment and cardiac tissue repair. This review summarizes current understanding in the field, elucidating the signaling mechanisms between cardiac ECM and residing cells in response to IHD onset. Furthermore, this review highlights recent advances in native ECM-mimicking cardiac matrices as a platform for modulating cardiac cell behavior and inducing cardiac repair.
缺血性心脏病(IHD),包括心肌梗死和心肌病,是全球范围内导致死亡和发病的主要原因。心脏来源的干细胞和祖细胞已被证明是治疗 IHD 的一种有前途的方法,但由于细胞存活率低、保留率有限和快速冲洗,其应用受到限制。一种解决方法是将细胞包裹在基质或三维结构中,以提供结构支撑并更好地模拟细胞在给药时的生理微环境。更具体地说,细胞外基质(ECM),即天然的细胞支持网络,是该目的的强有力候选者。此外,人们强烈认为 ECM 及其驻留细胞(包括心脏干细胞)在组织发育、衰老、疾病进展和修复过程中始终存在相互作用。当受到外部刺激时,细胞和 ECM 共同作用,通过最初改变 ECM 组成和刚度来相互维持局部内稳态,进而改变细胞的反应和行为。鉴于这种持续的相互作用,了解细胞-ECM 相互作用的双向机制对于开发更好的细胞植入基质以增强细胞植入和心脏组织修复至关重要。本综述总结了该领域的现有认识,阐明了心脏 ECM 与驻留细胞在 IHD 发生时的信号转导机制。此外,本综述还强调了模拟天然 ECM 的心脏基质作为调节心脏细胞行为和诱导心脏修复的平台的最新进展。